Harrow, Inc.

NasdaqGM:HROW Stock Report

Market Cap: US$1.2b

Harrow Future Growth

Future criteria checks 5/6

Harrow is forecast to grow earnings and revenue by 85.3% and 39.2% per annum respectively while EPS is expected to grow by 85.9% per annum.

Key information

85.3%

Earnings growth rate

85.9%

EPS growth rate

Pharmaceuticals earnings growth19.8%
Revenue growth rate39.2%
Future return on equityn/a
Analyst coverage

Low

Last updated04 Dec 2024

Recent future growth updates

Recent updates

Harrow: The Triesence Relaunch

Dec 14

Harrow: Spotlight On IHEEZO

Nov 16

Harrow's Focus - Reviving Old Drugs In A Crowded Market

Oct 02

Harrow: 3 Business Models, One Mission

Sep 10

Borrowing Cash To Burn It: The Curious Case Of Harrow

Aug 21

Harrow: The Bull Thesis Is On Track, But Short-Term Challenges Loom

May 02

Harrow's Drug Iheezo Is Off To A Great Start

Feb 19

Harrow: Temporary Disruption In Stock Price Creates Excellent Opportunity

Jan 30

Harrow sells non‑ophthalmic compounding business, terms undisclosed

Oct 05

Harrow Health soars ~27% on FDA nod of anesthesia gel for the surface of the eye

Sep 27

SRK Capital - Harrow Health: Market Missing The Forest For The Trees

Aug 19

These 4 Measures Indicate That Harrow Health (NASDAQ:HROW) Is Using Debt Extensively

Aug 11
These 4 Measures Indicate That Harrow Health (NASDAQ:HROW) Is Using Debt Extensively

Buy Deep Moated, Fast Growing, Superbly Managed Harrow Health Ahead Of New Product Launch

May 23

Does Harrow Health (NASDAQ:HROW) Have A Healthy Balance Sheet?

May 12
Does Harrow Health (NASDAQ:HROW) Have A Healthy Balance Sheet?

Is Harrow Health (NASDAQ:HROW) A Risky Investment?

Dec 15
Is Harrow Health (NASDAQ:HROW) A Risky Investment?

Does Harrow Health (NASDAQ:HROW) Have A Healthy Balance Sheet?

Aug 24
Does Harrow Health (NASDAQ:HROW) Have A Healthy Balance Sheet?

Earnings and Revenue Growth Forecasts

NasdaqGM:HROW - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2027705229N/A2701
12/31/202642791N/A1072
12/31/20252832146594
12/31/2024192-233134
9/30/2024169-3334N/A
6/30/2024154-34-210N/A
3/31/2024139-31-147N/A
12/31/2023130-24-1494N/A
9/30/2023114-14-167-9N/A
6/30/2023103-16-147-8N/A
3/31/202393-18-146-7N/A
12/31/202289-14-62N/A
9/30/202288-23-124N/A
6/30/202284-24-132N/A
3/31/202279-21-133N/A
12/31/202172-18-115N/A
9/30/202167-1046N/A
6/30/2021637911N/A
3/31/2021521023N/A
12/31/202049-3-2-1N/A
9/30/202047-2-11N/A
6/30/202045-22-3-2N/A
3/31/202051-2402N/A
12/31/2019510-11N/A
9/30/20195016-2-1N/A
6/30/20194825-30N/A
3/31/20194529-20N/A
12/31/20184115-21N/A
9/30/201837-6-10N/A
6/30/201833-9N/A-2N/A
3/31/201830-10N/A-6N/A
12/31/201727-12N/A-9N/A
9/30/201725-15N/A-11N/A
6/30/201724-13N/A-12N/A
3/31/201722-20N/A-13N/A
12/31/201620-19N/A-11N/A
9/30/201618-18N/A-12N/A
6/30/201615-18N/A-11N/A
3/31/201613-17N/A-11N/A
12/31/201510-16N/A-11N/A
9/30/20157-14N/A-10N/A
6/30/20155-12N/A-9N/A
3/31/20153-11N/A-8N/A
12/31/20142-10N/A-7N/A
9/30/20141-9N/A-6N/A
6/30/20141-9N/A-6N/A
3/31/20140-9N/A-5N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: HROW is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).

Earnings vs Market: HROW is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: HROW is expected to become profitable in the next 3 years.

Revenue vs Market: HROW's revenue (39.2% per year) is forecast to grow faster than the US market (9% per year).

High Growth Revenue: HROW's revenue (39.2% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if HROW's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/20 22:05
End of Day Share Price 2025/01/17 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Harrow, Inc. is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mayank MamtaniB. Riley Securities, Inc.
Chase KnickerbockerCraig-Hallum Capital Group LLC
Matthew HewittCraig-Hallum Capital Group LLC